Teamwork cuts out unnecessary biopsies, researchers find

Unnecessary biopsies could be a thing of the past for patients undergoing treatment for head and neck cancer. New Saint Louis University research found that when nuclear medicine clinicians and treating physicians work together to interpret PET-CT scan results, the accuracy dramatically improves, sparring patients unnecessary pain and suffering.

Often used prior to and after cancer treatment, the highly sensitive PET-CT has improved the ability to detect and treat head and neck cancer. However, it can give a significant number of false positive results, which then require a biopsy to rule out cancer that could have been left behind during the initial treatment.

According to Mark Varvares, M.D., the study's lead author and the Donald and Marlene Jerome Endowed Chair in Otolaryngology - Head and Neck Surgery at Saint Louis University, both nuclear medicine and treating physicians have become better at interpreting PET-CT scans.

"If we improve the accuracy of the scans by including clinical information, the treating physician or cancer specialist will be able to say with confidence that we do not need to biopsy something – that it's just post-operative inflammation."

Unnecessary biopsies are dangerous for head and neck cancer patients who have already undergone intensive radiation and chemotherapy. It can create a non-healing situation that can result in a catastrophic event, such as needing to remove the voice box, Varvares explained.

Varvares and his colleagues studied the scan results of 180 head and neck cancer patients who had undergone evaluation with PET-CT prior to and after treatment. To study the added value of including clinical information, they compared the incidence of false positive findings from PET-CT scans with those that both nuclear medicine and treating physicians had evaluated.

Alone, PET-CT scans produced a false positive rate of 65 percent and a false negative rate of 8 percent. However, when clinical information was included, the false positive rate dropped to 14 percent and the false negative rate dropped to 2 percent.

"Excellent communication between the nuclear medicine physician and treating clinician is crucial to improving scan accuracy," Varvares said.

In addition to improving the care of head and neck cancer patients, Varvares says that improving the accuracy of PET-CT scans and limiting the number of biopsies needed has the potential to be more cost-effective.

The research findings were presented on Tuesday, July 22 at the 7th International Conference on Head and Neck Cancer in San Francisco, Calif.

Source: Saint Louis University

Related stories:

FDA posts list of potential problem drugs
(AP) -- The government on Friday began posting a list of prescription drugs under investigation for potential safety problems, in an effort to better inform doctors and patients.
Scientists nail childhood nerve cancer gene
Researchers have identified the hereditary gene mutations behind a deadly form of childhood cancer, opening the way to genetic tests in high-risk families, according to study released Sunday.
Hair on a man's head offers clues about prostate cancer
Some of the drugs given to many men during their fight against prostate cancer can actually spur some cancer cells to grow, researchers have found. The findings were published online this week in a pair of papers in the Proceedings of the National Academy of Sciences.
First detection of 'odor profile' for skin cancer may lead to rapid, non-invasive diagnostic test
Chemists today described the first identification of a specific "odor profile" for skin cancer, a discovery that could form the basis of a rapid, non-invasive test for diagnosing the most common type of cancer in the United States. The findings may enable doctors in the future to diagnose skin cancer quickly and accurately by waving a handheld scanner or sensor above the skin, they reported today at the 236th national meeting of the American Chemical Society.
MIT engineers work toward cell-sized batteries
(PhysOrg.com) -- Forget 9-volts, AAs, AAAs or D batteries: The energy for tomorrow’s miniature electronic devices could come from tiny microbatteries about half the size of a human cell and built with viruses.
By amplifying cell death signals, scientists make precancerous cells self-destruct
When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction.
'Don't Worry Be Happy': happiness is key to longer life
Keep humming "Don't Worry Be Happy". The 1980s New Age-inspired hit got it right. New research shows being happy can add several years to life.
Using live fish, new tool a sentinel for environmental contamination
Researchers have harnessed the sensitivity of days-old fish embryos to create a tool capable of detecting a range of harmful chemicals.

News discussion:

Medicine & Health news